Literature DB >> 20212934

The child with epiphora.

W N Clarke1.   

Abstract

Entities:  

Year:  1999        PMID： 20212934      PMCID： PMC2827722          DOI： 10.1093/pch/4.5.325

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  5 in total

1.  Medical management of congenital nasolacrimal duct obstruction.

Authors:  L R Nelson; J H Calhoun; H Menduke
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

2.  Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis.

Authors:  J Kassoff; D R Meyer
Journal:  Arch Ophthalmol       Date:  1995-09

3.  Conservative management of congenital nasolacrimal duct obstruction.

Authors:  P Nucci; C Capoferri; R Alfarano; R Brancato
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1989 Jan-Feb       Impact factor: 1.402

Review 4.  Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention.

Authors:  T O Paul; R Shepherd
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1994 Nov-Dec       Impact factor: 1.402

5.  Photophobia, epiphora, and torticollis: a masquerade syndrome.

Authors:  M A Marmor; G R Beauchamp; S F Maddox
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1990 Jul-Aug       Impact factor: 1.402
  5 in total
  3 in total

1.  Unilateral epiphora in an adolescent.

Authors:  P Tevaraj; N M Ibrahim
Journal:  Malays Fam Physician       Date:  2014-08-31

2.  Prevalence of Eye Problems among Young Infants of Rohingya Refugee Camps: Findings from a Cross-Sectional Survey.

Authors:  Ahm Enayet Hussain; Zunayed Al Azdi; Khaleda Islam; Anm Ehtesham Kabir; Rumana Huque
Journal:  Trop Med Infect Dis       Date:  2020-02-04

3.  Management of congenital nasolacrimal duct obstruction: results of a national survey of paediatric and oculoplastic ophthalmologists.

Authors:  Vidushi Golash; Harpreet Kaur; Sarju Athwal; Rebiye Chakartash; Masara Laginaf; Mona Khandwala
Journal:  Eye (Lond)       Date:  2020-09-16       Impact factor: 4.456
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.